Cargando…

Linking atrial fibrillation with non-alcoholic fatty liver disease: potential common therapeutic targets

Non-alcoholic fatty liver disease (NAFLD) and atrial fibrillation (AF) are common chronic non-infectious diseases with rising incidences. NAFLD is an independent risk factor for the onset of AF, after adjusting potentially related factors. The pathogenesis of these diseases share several mechanisms...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Ya-Hui, Ma, Yuan, Qian, Lin-Yan, Xu, Qiang, Wang, Li-Hong, Huang, Dong-Sheng, Zou, Hai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601170/ https://www.ncbi.nlm.nih.gov/pubmed/28948002 http://dx.doi.org/10.18632/oncotarget.19522

Ejemplares similares

Nonalcoholic fatty liver disease and atrial fibrillation: possible pathophysiological links and therapeutic interventions
por: Haghbin, Hossein, et al.
Publicado: (2020)

Link Between Non-Alcoholic Fatty Liver Disease and Atrial Fibrillation: A Systematic Review and Meta-Analysis
por: Minhas, Abdul M, et al.
Publicado: (2017)

Association between Atrial Fibrillation and Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
por: Kang, Min Kyu, et al.
Publicado: (2020)

Exploring immune related gene signatures and mechanisms linking non alcoholic fatty liver disease to atrial fibrillation through transcriptome data analysis
por: Wu, Keke, et al.
Publicado: (2023)

Association between the Triglyceride–Glucose Index and Non-Alcoholic Fatty Liver Disease in patients with Atrial Fibrillation
por: Li, Xiaozhong, et al.
Publicado: (2023)

Impact of advanced liver fibrosis on atrial fibrillation recurrence after ablation in non-alcoholic fatty liver disease patients
por: Wang, Zhe, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease impacts the control of the international normalized ratio in patients with atrial fibrillation
por: Zhang, Xi, et al.
Publicado: (2020)

Non-Alcoholic Fatty Liver Disease Is Associated with an Increased Incidence of Atrial Fibrillation in Patients with Type 2 Diabetes
por: Targher, Giovanni, et al.
Publicado: (2013)

Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study)
por: Käräjämäki, Aki J., et al.
Publicado: (2015)

The risk of atrial fibrillation in patients with non-alcoholic fatty liver disease and a high hepatic fibrosis index
por: Park, Hyo Eun, et al.
Publicado: (2020)

Correlation between the triglyceride-glucose index and the onset of atrial fibrillation in patients with non-alcoholic fatty liver disease
por: Zhang, Yao, et al.
Publicado: (2023)

Mediterranean Diet: A Tool to Break the Relationship of Atrial Fibrillation with the Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease
por: Biccirè, Flavio Giuseppe, et al.
Publicado: (2022)

Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management
por: Jichitu, Alexandra, et al.
Publicado: (2021)

Non-alcoholic Fatty Liver Disease and the Risk of Incident Atrial Fibrillation in Young Adults: A Nationwide Population-Based Cohort Study
por: Choi, JungMin, et al.
Publicado: (2022)

Lack of authentic atrial fibrillation in commonly used murine atrial fibrillation models
por: Fu, Fumin, et al.
Publicado: (2022)

Alcohol consumption in relation to the incidence of atrial fibrillation in an elderly Chinese population
por: YE, Xiao-Fei, et al.
Publicado: (2022)

Alcohol Consumption, Left Atrial Diameter, and Atrial Fibrillation
por: McManus, David D., et al.
Publicado: (2016)

Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view
por: Chen, Hui-Ting, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study
por: Pastori, Daniele, et al.
Publicado: (2021)

Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism
por: Kim, Tae Hyun, et al.
Publicado: (2021)

Obesity as the common soil of non‐alcoholic fatty liver disease and diabetes: Role of adipokines
por: Hui, Elaine, et al.
Publicado: (2013)

Characteristics of Atrial Fibrillation Patients Suffering Esophageal Injury Caused by Ablation for Atrial Fibrillation
por: Zhang, Pei, et al.
Publicado: (2020)

Association of blood pressure level with nonalcoholic fatty liver disease in nonhypertensive population: Normal is not the new normal
por: Qian, Lin-Yan, et al.
Publicado: (2016)

Omega-3 fatty acids and atrial fibrillation
por: Huh, Ji Hye, et al.
Publicado: (2023)

Atrial Fibrillation:: A Common Cause of Stroke
por: Tai, Waimei
Publicado: (2023)

Postoperative atrial fibrillation and atrial epicardial fat: Is there a link?
por: van der Heijden, Claudia A.J., et al.
Publicado: (2022)

Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease
por: Fu, Yajie, et al.
Publicado: (2022)

Emerging Diagnostics and Therapeutics for Non-alcoholic Fatty Liver Disease
por: Darbhanga, Jake, et al.
Publicado: (2023)

Preexisting atrial fibrillation and myocardial infarction: only 10% of infarcts directly linked to atrial fibrillation
por: Putot, Alain, et al.
Publicado: (2022)

Association of atrial fibrillation and gastroesophageal reflux disease: Natural and therapeutic linkage of the two common diseases
por: Maruyama, Toru, et al.
Publicado: (2018)

Linking Electrical Drivers With Atrial Cardiomyopathy for the Targeted Treatment of Atrial Fibrillation
por: Ho, Gordon, et al.
Publicado: (2020)

Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma
por: Raza, Sana, et al.
Publicado: (2019)

Waist-to-height ratio and non-alcoholic fatty liver disease in adults
por: Sheng, Guotai, et al.
Publicado: (2021)

Hepatic Unsaturated Fatty Acids Are Linked to Lower Degree of Fibrosis in Non-alcoholic Fatty Liver Disease
por: Fridén, Michael, et al.
Publicado: (2022)

Pyroptotic MAITs link microbial translocation with severity of alcohol-associated liver disease
por: Zhang, Li-Ping, et al.
Publicado: (2023)

Impact of Non-Alcoholic Simple Fatty Liver Disease on Antituberculosis Drug-Induced Liver Injury
por: Liu, Yi-Hui, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease in patients with psoriasis: therapeutic implications
por: Klujszo, Elzbieta H., et al.
Publicado: (2019)

The New Therapeutic Approaches in the Treatment of Non-Alcoholic Fatty Liver Disease
por: Filipovic, Branka, et al.
Publicado: (2021)

Pathogenesis and Therapeutic Strategies Related to Non-Alcoholic Fatty Liver Disease
por: Teng, Tieshan, et al.
Publicado: (2022)

The correlation between gut microbiome and atrial fibrillation: pathophysiology and therapeutic perspectives
por: Li, Na, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t0lk4a393kk5p5vpg6gff8i59b